Hong Kong Science & Technology Parks Corporation (HKSTP) is the largest innovation and technology hub in Hong Kong. It fosters a vibrant ecosystem for startups, enterprises, and researchers, offering incubation, acceleration, and investment opportunities. HKSTP operates Science Park, InnoCentre, and InnoParks across Hong Kong, driving advancements in life sciences, AI, fintech, and more. With strong global partnerships, state-of-the-art facilities, and talent development programs, HKSTP accelerates innovation and commercialization, contributing to Hong Kong’s position as a regional I&T leader.
HEAL ITALIA FOUNDATION
The Heal Italia Foundation it is established thanks to the European Union-funded project “Health Extended Alliance for Innovative Therapies, Advanced Lab-research and Integrated Approaches of Precision Medicine”. It represents today the Italian strategic cluster in the Life Sciences sector, with a specific focus on Precision Medicine. Headquartered in Palermo, Rome, and soon also in Milan and Brussels, it coordinates a multidisciplinary network of over 70 entities (see https://www.healitalia.eu/partner/) including 33 Universities, IRCCS, and companies. The goal is to share knowledge, research, and innovative technologies to support the Italian research and healthcare system in defining new models and approaches for the prevention, diagnosis, and treatment of chronic diseases, with primary focus on oncological, cardiovascular, metabolic, rare, and neurodegenerative conditions. The Foundation: • coordinates a network of over 600 researchers operating throughout Italy; • benefits, through its partner network, from a large project portfolio with over 250 ongoing studies, and from products and/or technologies protected by over 1000 patents; • develops new models and approaches for Precision Medicine through the use and testing of 5.0 technologies (Artificial Intelligence, Big Data, Supercomputing Systems) in preclinical, clinical, and translational fields; • supports pharmaceutical research also through the first Core Facility that brings together accredited Biobanks, GMP, Data Networks, and Cell Factories; • launched in 2023 the first National PhD Program in Precision Medicine. Acting as a Fund Agency, supports the acquisition of specific funds and grants for researchers and/or startups working on innovative projects in precision medicine. It also directly finances research projects and startups to promote applied research and technology transfer, accelerating the development and commercialization of advanced technological solutions.
Government of Tamil Nadu – Guidance & TICEL Bio Park Limited
Guidance TamilNadu Guidance Tamil Nadu is the investment promotion agency of the Government of Tamil Nadu, India’s most industrialized state. With a robust and diverse industrial ecosystem, Tamil Nadu is advancing its biotechnology sector with a focused, mission-driven approach. As a single-window facilitation body, Guidance offers end-to-end support to investors through a dedicated team of sector specialists, policy advisors, and international consultants. We streamline the investment journey by coordinating with industry stakeholders, community partners, and government departments—consolidating efforts to ensure a seamless and efficient business experience. In the life sciences sector, Guidance’s primary objective is to position Tamil Nadu as the investment destination of choice. This is achieved by enhancing ease of doing business, reducing operational costs, enabling policy frameworks tailored to the evolving global life sciences landscape, and providing sustained, expert-backed support throughout the investment lifecycle. TICEL Biopark Limited TICEL Biopark Limited, Chennai, Tamil Nadu, India is a state – of – art Biotechnology Park established in 2004 in Tamil Nadu, India. TICEL Biopark is promoted by TIDCO (Tamil Nadu Industrial Development Corporation) in technical collaboration with Cornell University, USA. TICEL Biopark supports Biotech ecosystem from their early stage of research to pilot-scale production by providing laboratory infrastructure and equipment support. Major companies such as Biocon biologics, Teva pharma, Levim biotech, Amway, Johnson & Johnson, Hiyoshi India and Revvity Health sciences are located in Ticel Bio Park. The Biotech Core Instrumentation Facility, housed at TICEL Biopark, provides equipment support to startups and industries. TICEL provides Laboratory infrastructure which supports to create GMP/GLP/ Contract Research (CRO) / Contract Manufacturing (CMO) / testing facility. TICEL infrastructure includes utilities such as RO water plant, Gas Bank, Vacuum air, Compressed air, Fume hood exhaust with scrubber, HVAC system, Bio waste disposal, STP & ETP plant etc. TICEL supports startups/Industries by providing equipment, incubation space, and resources to conduct research and commercialize their products. TICEL also conducts skill development programs and hands-on workshops for students and scientific professionals. Additionally, TICEL undertakes contract research and contract manufacturing work at its Biotech Core Instrumentation Facility.
Gevers Belgium
Gevers is a leading European firm specializing in intellectual property (IP) services, with over 125 years of experience in empowering innovation. Headquartered in Belgium and France, Gevers provides expert support in patents, trademarks, designs, copyrights, and tailor-made IP strategies, helping businesses protect, manage, and maximize the value of their innovations. Gevers partners with visionary entrepreneurs, pioneering companies, and research institutions to secure their competitive edge in a fast-evolving world. Driven by its mission “Empowering Innovation,” Gevers acts as a guardian of progress — combining deep legal expertise with a proactive, down-to-earth, and entrepreneurial spirit. From initial IP filings to complex enforcement cases and strategic advisory, Gevers is a trusted ally throughout the innovation lifecycle.
German Pavilion
1) Presented by: Federal Ministry for Economic Affairs and Energy (BMWE) internet: www.bundeswirtschaftsministerium.de 2) in Cooperation with: AUMA_Association of the German Trade Fair Industry internet: www.auma-messen.de 3) supported by: SPECTARIS – German industry association for Optics, Photonics, Analytical and Medical Technologies internet: www.spectaris.de 4) organized by: IEC Inter Expo Consult GmbH internet: www.iecberlin.de Germany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location. | Welcome to the German Pavilion. | Germany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location. | Germany participates with a company joint presentation which is presented by the Federal Ministry for Economic Affairs and Energy and supported by AUMA – Association of the German Trade Fair Industry and organized by Hannover Fairs International GmbH. | Brands:Emanuel Wilfer e. K., WITTNER GmbH & Co. KG, Karl Höfner GmbH & Co. KG, Paesold, Doerfler Bows, Schlagwerk GmbH, Instruments of Things, Geller Ebonit, Traps Drums Profi Sound | Bundesverband der deutschen Musikinstrumentenhersteller e.V.Brunnenstr.3165191 WiesbadenDeutschland Tel +49 611 954588-6Fax +49 611 954588-5Mobil +49 172 683750-0 | Official German Pavilion sponsored from the Ministry of Economics – Organized from IEC Berlin. Exhibitors 2026: Klangio Wilde+Spieth Roderich Paesold Höfner Brandenburg Labs Streamsoft Fraunhofer IDMT Institutsteil Verband Deutscher Tonmeister e. V. Georg Neumann GmbH Sennheiser Research and Development GmbH GEWA music GmbH Schlagwerk GmbH | Welcome to the German Pavilion! We warmly invite you to visit more than 30 exhibitors from Germany and discover their latest technologies, innovative solutions, and high-quality services. Take the opportunity to connect with industry experts and explore new business possibilities in a dynamic international environment. In addition, learn more about Germany as an attractive travel destination, offering a unique combination of culture, innovation, and hospitality. We look forward to welcoming you! | German Pavilion Booth No. 3826Federal Ministry for Economic Affairs and Energy (BMWE)in Cooperation with AUMA Association of the German Trade Fair IndustryInternet: The Battery Show North America 2025 / German PavilionGermany participates with a “German Pavilion” offering a professional brokerage service to help to establish contacts with German companies and comprehensive information on Germany as an important business location.
GeneQuantum Healthcare (Suzhou) Co.,Ltd
GeneQuantum (GQ) is a leading ADC biotech company with proprietary one-enzyme-one-reaction bioconjugation technology and highly stable hydrophilic linkers that can generate the next generation of ADC molecules with: 1) homogeneous and site-specific conjugation for DAR2, DAR4, DAR6 and DAR8; 2) super stability with DAR value remains stable for >7 days in circulation; 3) 100% removal of ADCC without antibody engineering. We have established a highly differentiated ADC pipeline with 3 clinical stage programs, one pre-clinical program (out-licensed to Pyramid/Biohaven), and multiple programs including dual-payload ADC and radionuclide drug conjugates (RDC). Our ADC technology can be pluged & played into the current antibody manufacturing facility – no need for building dedicated ADC facilities. A number of global leading CDMOs including Wuxi XDC have licensed our technology and already completed GMP production for clinical supply. | GeneQuantum (GQ) has developed a strong pipeline of next-gen of ADCs with wider therapeutic window & higher affordability with its proprietary One-Enzyme-One-Reaction bioconjugation technology (DAR2/4/6/8, super stable both in circulation and in storage in liquid form, ADCC depletion w/o Fc engineering, ADCs manufactured in mAb facility, dual payload pADCs, RDCs, and AOCs, etc.) with 5 clinical programs including 1 currently in registration trial in China. Strategic Collaborations: Biohaven: out licensed the global right of GQ1011 (anti-FGFR3 ADC ) Biohaven: long term strategic collaboration to develop ADCs on multi-targets AimedBio: long term strategic collaboration to develop ADCs on multi-targets Pyramid: out licensed the ex-China right of GQ1010 (anti-TROP2 ADC) 2024 BD Milestone: executed 4 out-licensing deals in 2024 with total US$13B Bio$, the most # of deals done by a Chinese ADC in 2024
Fundación INCIDE
The Innovation and Science Foundation for Business Development (INCIDE) is a non-profit organization, founded in 2013 by a group of mexican pharmaceutical companies, committed to technological development and innovation. INCIDE was created with the purpose of promoting scientific and technological development, as well as innovation, in biotech companies to generate value and competitive advantages and to collaborate in the economic and social development of companies and the country. The founding entrepreneurs have been shareholders of companies with more than 60 years in the pharmaceutical market, achieving their success on innovation processes that have projected them to generate patents and successfully venture into international markets. Our philosophy led us to collaborate with Universities and Public Research centers in order to foster science, technology and innovation in the pharma and health sectors. We implement 3 main open innovation strategies for Mexican pharmaceutical companies: 1) we run a program of innovation challenges where pharma companies identify a problem that need to be solved and we launch and open call to identify feasible solutions. The winners are funded to implement the selected project; 2) we launch an open call to incubate startups with pharma and health developments in early stage (since TRL 3) and prepare them to raise capital with Venture Capital Funds; 3) We are contributing to conform a Multi Corporate Venture Capital with investment thesis in health for startups in early stages (seed, pre Serie A and A Series). Finally, we also help Mexican pharma companies to identify in licensing opportunities for Mexican and Latinamerican markets, with a focus in small mollecules, vaccines, monoclonal antibodies and drug delivery systems. | The Fundación Innovación y Ciencia para el Desarrollo Empresarial (INCIDE) is a non-profit organization established in 2013, the result of a joint commitment by a group of Mexican companies with over six decades of experience, primarily in the pharmaceutical sector. These companies have built their growth and longevity on sustained processes of innovation, technological development, and patent generation, enabling them to compete successfully in international markets. The foundation fosters effective collaboration among companies, universities, and research centers, facilitating the creation of new technology-based enterprises and increasing private investment in science, technology, and innovation. Are you an academic / research institution looking for connection with mexican pharmaceutical companies? Let’s talk. INCIDE operates a Technology Observatory, a specialized tool for generating technology intelligence studies that help identify commercial opportunities, anticipate emerging technological trends, and support strategic decision-making in innovation. Are you interested in a Report that includes patents, clinical trials, resaerch projects funded, academic literature, market info, etc? Let’s talk. Additionally, INCIDE leads various technology scaling programs, including Innovation’s Challenge, an initiative carried out in collaboration with local government stakeholders to enhance public-private partnerships. Are you interested in solving the problems that mexican pharma companies have? Let’s talk about. The foundation also launches calls for the incubation of health-related technological products, through which investment portfolios are built for licensing innovations and accelerating their market entry. Are you an startup in early stage looking for tech transfer agreements with mexican pharma companies? Let’s talk. Its strategic objectives include identifying opportunities, managing portfolios of innovation and technological development projects, and promoting the active participation of both large enterprises and SMEs with innovation capacities. Furthermore, INCIDE seeks to position itself as an ethical and transparent entity that delivers concrete and measurable results for its members and for society at large.
Empire State Development
. | New York’s diversity and strengths are enabling groundbreaking life science innovation… Through strategic investment in biopharmaceutical, device and diagnostic research, development and manufacturing, New York fuels the creation of cutting-edge healthcare solutions. New York is growing its life science industry through a broad range of economic development programs and public-private partnerships, supported by the state’s award-winning research talent. New York is expanding the state’s ability to commercialize research and spurring the growth of a world-class life science research cluster. | New York’s diversity and strengths are enabling groundbreaking life science innovation through strategic investment in biopharmaceutical, device and diagnostic research, development and manufacturing, New York fuels the creation of cutting-edge healthcare solutions. New York is growing its life science industry through a broad range of economic development programs and public-private partnerships, supported by the state’s award-winning research talent. And through its $620 million Life Science Initiative, New York is expanding the state’s ability to commercialize research and spurring the growth of a world-class life science research cluster. The mission of Empire State Development (“ESD”) is to promote a vigorous, inclusive and growing state economy, encourage business investment and job creation, and support diverse, local economies across New York State through the efficient use of loans, grants, tax credits, real estate development, marketing, and other forms of assistance. To support our economic development mission, ESD: invests strategically in infrastructure, innovation, place-making and revitalization, tradable sectors, and workforce development, with a focus on sustainability and historically disadvantaged populations across the state; is transparent and responsive to the needs of diverse communities and businesses across the state, including through the active participation of the Regional Councils; supports the retention and growth of existing businesses, the resilience of communities, and the development of new businesses and industries; promotes equality of economic opportunities for minority- and women-owned businesses (“MWBEs”) and Service-Disabled Veteran-Owned Businesses (“SDVOBs”); assists in the development of underutilized property to spur community revitalization, housing, and commercial activity; provides early-stage support for new ventures, including the research and development and commercialization of new technologies; and strengthens New York State’s innovation-based economy through partnerships with our acclaimed universities, promoting entrepreneurialism through the development of incubators and next-generation manufacturing and technology hubs across the state. | Empire State Development (ESD) is the lead economic development agency for New York and offers site selection support and access to robust incentives, including the $3B excelsior tax credit program which is enhanced for green projects. ESD focuses on attracting strategic industries including energy storage, while also investing significantly into preparing industrial sites. ESD facilitates the $400m FAST NY shovel ready grant program as well as the $300m POWER UP initiative. Together, these programs seek to create shovel ready, power ready sites well suited to advanced manufacturing. To date, the FAST NY program has improved over 4,000 acres of industrial property. The strategic business team at ESD provides tailored service to companies seeking sites, incentives, workforce information, at local connections in New York.
Economic Promotion Valais
Valais is a leading Swiss canton in the life sciences industry: • 2nd Swiss canton; • largest Bio manufacturing facility in Europe; with an outstanding network of competences with strong track records in Pharma, Biotech and Medtech. Our highly qualified environment allows a fast growing and development of products from early stage to commercialization. Valais is an unavoidable and rich resource for pharmaceuticals, chemical and biotechnologies, enabling technologies and special service providers backed by world-class engineering and science (4 R&D centres and 2’000 researchers). From the beginning of the 20th century, Valais has attracted numerous companies who operate in the field of pharmaceuticals and chemistry. Those early pioneers have now become international groups recognised for the quality of their products. Furthermore, Valais benefits from the presence of renowned multinationals such as Siegfried, Lonza, Bachem, IHMA, Kodiak Sciences, TRB Chemica, ExcellGen and Debiopharm Research & Manufacturing. At the BioArk and PhytoArk sites, Valais has created a focus on the following areas of expertise: • Biotechnologies, pharma, chemicals • Cosmetics • Medical diagnostics • Agrofood (phyto and nutraceuticals) A single point of contact, Economic Promotion Valais, ensures a fast and effective response to requests from companies, investors and the business communities. | Economic Promotion Valais and its multidisciplinary team are at your disposal to support your entrepreneurial development, whatever stage your company is at. Whatever your business needs—be it financial assistance or help with innovation projects, raising of funds, technology transfer, networking within the local business ecosystem, or getting started—Economic Promotion Valais will do all it can to ensure that your company prospers in our region. Our services are free of charge. | Leading home of the Swiss Biopharma industry, Valais gathers the main players of the sector and Economic Promotion Valais will help to be part of this outstanding life sciences community. Medicine, research, pyrotechnics, pharmaceutical products, packaging technology… A wide variety of cutting-edge companies in the fields of pharmaceuticals, chemistry and biotechnology are based in Valais. They are renowned for their skills and the high quality of their products, often exported worldwide. This sector of Valais industry represents a genuine centre of expertise focused on innovation and generating a great deal of added value for the canton – regarded as number two in the sector in Switzerland.
Discovery to Impact, University of Texas at Austin
The Discovery to Impact team at The University of Texas at Austin brings research discoveries to the marketplace to impact the world. Working with world-class inventors, investors, creators and entrepreneurs, we launch startups and collaborate with established businesses to accelerate new products, services, solutions and cures. We deliver results to contribute to UT Austin’s mission to be the world’s highest-impact public research university, unleashing knowledge, opportunity and innovation from the heart of Texas. And we relentlessly pursue our part of fulfilling UT’s promise: What starts here changes the world